Cancer/testis antigen expression in human mesenchymal stem cells : Down-regulation of SSX impairs cell migration and matrix metalloproteinase 2 expression

• Published in: Cancer research (Chicago, Ill.) Vol. 65; no. 6; pp. 2207 - 2215
• Main Authors: CRONWRIGHT, Garth, LE BLANC, Katarina, GÖTHERSTRÖM, Cecilia, DARCY, Padraig, EHNMAN, Monika, BRODIN, Bertha
• Format: Journal Article
• Language: English
• Published: Philadelphia, PA American Association for Cancer Research 15-03-2005
• Subjects: Antigens, Neoplasm - biosynthesis; Antigens, Neoplasm - genetics; Antineoplastic agents; Biological and medical sciences; Bone Marrow Cells - cytology; Bone Marrow Cells - metabolism; Cell Differentiation - genetics; Cell Line, Tumor; Cell Movement - genetics; Down-Regulation; Humans; Matrix Metalloproteinase 2 - biosynthesis; Medical sciences; Medicin och hälsovetenskap; Melanoma - genetics; Melanoma - immunology; Melanoma - metabolism; Melanoma - pathology; Melanoma-Specific Antigens; Membrane Proteins - genetics; Mesenchymal Stromal Cells - cytology; Mesenchymal Stromal Cells - enzymology; Mesenchymal Stromal Cells - immunology; Mesenchymal Stromal Cells - metabolism; Neoplasm Proteins - biosynthesis; Neoplasm Proteins - genetics; Pharmacology. Drug treatments; Repressor Proteins - biosynthesis; Repressor Proteins - genetics; Vimentin - metabolism; Human; Cancer testis antigen; Tumor associated antigen; Enzyme; Stem cell; Metalloendopeptidases; Mesenchymal cell; Gene expression; Gelatinase A; Peptidases; Cell motility; Regulation(control); Hydrolases; Cell migration
• ISSN: 0008-5472; 1538-7445
• DOI: 10.1158/0008-5472.CAN-04-1882

Several families of genes by and large located on the X chromosome encode proteins of unspecified function. Commonly known as cancer/testis (CT) antigens, they are considered, under normal conditions, only to be expressed in cells of the germ line and placenta. CT genes are also often expressed in cancer cells, hence their classification. Here we report that their expression in normal cells is wider spread and can be observed in cells with the potential for self-renewal and pleuripotency, namely, stem cells. Several CT genes and their products, CT antigens, including SSX, NY-ESO-1, and N-RAGE, were expressed in undifferentiated mesenchymal stem cells (MSCs) and down-regulated after osteocyte and adipocyte differentiation. To elucidate the possible overlapping function played by these genes in cancer and stem cells, a comparative analysis of the localization of their proteins was made. In addition, localization relative to other MSC markers was examined. This revealed that SSX localizes in the cytoplasm and overlap occurs in regions where matrix metalloproteinase 2 (MMP2) and vimentin accumulate. Nevertheless, it was found that no protein interactions between these molecules occur. Further investigation revealed that the migration of a melanoma cell line (DFW), which expresses SSX, MMP2, and vimentin, decreases when SSX is down-regulated. This decrease in cell migration was paralleled by a reduction in MMP2 levels. Analogous to this, SSX expression is down-regulated in MSCs after differentiation; concomitantly a reduction in MMP2 levels occurs. In addition, E-cadherin expression increases, mimicking a mesenchymal epithelial transition. These results afford SSX a functional role in normal stem cell migration and suggest a potentially similar function in cancer cell metastases.